TARA – protara therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Protara Therapeutics (TARA) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $27.00 price target on the stock.
Protara Therapeutics Highlights TARA-002 NMIBC Data, FDA Plans for Lymphatic Malformations at Oppenheimer Conf [Yahoo! Finance]
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Protara Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Protara Therapeutics to Participate in Upcoming Investor Conferences
Form 144 Protara Therapeutics, Filed by: 667, L.P.
Form 144 Protara Therapeutics, Filed by: Baker Brothers Life Sciences LP
Form SCHEDULE 13G Protara Therapeutics, Filed by: MILLENNIUM MANAGEMENT LLC
Form 144 Protara Therapeutics, Filed by: 667, L.P.
Form 144 Protara Therapeutics, Filed by: Baker Brothers Life Sciences LP
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.